Midterm Outcomes: A Comprehensive Approach to Surgery for Hypertrophic Obstructive Cardiomyopathy

Lye-Yeng Wong1, Ruben Vila2, Gurion Lantz2

  • 1Division of Cardiothoracic Surgery, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, California.

PubMed

Insights

A comprehensive surgical approach for obstructive hypertrophic cardiomyopathy (HCM) significantly improves left ventricular outflow tract (LVOT) obstruction and mitral regurgitation, leading to excellent patient outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Hypertrophic Cardiomyopathy Research

Background:

  • Obstructive hypertrophic cardiomyopathy (HCM) involves complex left ventricular outflow tract (LVOT) abnormalities.
  • Surgical intervention aims to correct these multifaceted issues.

Purpose of the Study:

  • To evaluate the midterm outcomes of a comprehensive surgical strategy for LVOT obstruction in HCM.
  • To assess the effectiveness of addressing associated mitral valve and myocardial abnormalities.

Main Methods:

  • Single-institution retrospective study of 103 HCM patients undergoing septal myectomy (2016-2023).
  • Tracking of New York Heart Association (NYHA) functional class, LVOT gradient, and mitral valve function pre- and post-procedure.
  • Surgical techniques included septal myectomy, mitral valve repair/resection, and myocardial band resection.

Main Results:

  • Preoperative LVOT gradient averaged 36.4 mm Hg, with 50.5% experiencing moderate/severe mitral regurgitation.
  • Post-surgery, 91% of patients achieved NYHA functional class I or II.
  • Mean LVOT gradient decreased to 11 mm Hg, and only 1 patient had >mild mitral regurgitation post-operatively.

Conclusions:

  • A comprehensive surgical approach addressing all HCM-related abnormalities yields outstanding midterm results.
  • This strategy effectively resolves LVOT obstruction and improves mitral valve function.
  • Surgical correction offers significant functional improvement for patients with obstructive HCM.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460